Format

Send to

Choose Destination
EBioMedicine. 2015 Jun 10;2(7):690-8. doi: 10.1016/j.ebiom.2015.05.021. eCollection 2015 Jul.

Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.

Author information

1
Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
2
Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
3
Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
4
Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla CA 92093, USA.
5
Central Facility for Microscopy, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
6
Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA ; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA ; Rady Children's Hospital, San Diego, CA 92123, USA.

Abstract

Antibiotic resistance poses an increasingly grave threat to the public health. Of pressing concern, rapid spread of carbapenem-resistance among multidrug-resistant (MDR) Gram-negative rods (GNR) is associated with few treatment options and high mortality rates. Current antibiotic susceptibility testing guiding patient management is performed in a standardized manner, identifying minimum inhibitory concentrations (MIC) in bacteriologic media, but ignoring host immune factors. Lacking activity in standard MIC testing, azithromycin (AZM), the most commonly prescribed antibiotic in the U.S., is never recommended for MDR GNR infection. Here we report a potent bactericidal action of AZM against MDR carbapenem-resistant isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. This pharmaceutical activity is associated with enhanced AZM cell penetration in eukaryotic tissue culture media and striking multi-log-fold synergies with host cathelicidin antimicrobial peptide LL-37 or the last line antibiotic colistin. Finally, AZM monotherapy exerts clear therapeutic effects in murine models of MDR GNR infection. Our results suggest that AZM, currently ignored as a treatment option, could benefit patients with MDR GNR infections, especially in combination with colistin.

KEYWORDS:

Acinetobacter baumannii; Antibiotic resistance; Antimicrobial peptides; Azithromycin; Cathelicidin; Colistin; Klebsiella pneumoniae; LL-37; Macrolides; Pseudomonas aeruginosa

Comment in

PMID:
26288841
PMCID:
PMC4534682
DOI:
10.1016/j.ebiom.2015.05.021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center